Furthermore, large cohort studies focusing on the relationship between DIO3 expression and GIST, as well as the potential therapeutic implications, could provide valuable insights into the molecular mechanisms underlying GIST pathogenesis and treatment response. This evidence concerns the gene DIO3 and gastrointestinal stromal tumor.